Michigan Institute of Urology
News and Media Coverage
Town Center ASC Among 2025 Best Ambulatory Surgery Centers
U.S. News & World Report Names Michigan Institute of Urology’s Town Center ASC Among 2025 Best Ambulatory Surgery Centers Detroit, Mich. – April 15, 2025 – Michigan Institute of Urology’s (MIU) Town Center ASC in Troy has been recognized among [...]
Investigational Combination Immunotherapy Treatment for High-Risk, Late-Stage Prostate Cancer Patients Available in Michigan
Michigan Institute of Urology is a clinical trial site for LEGION-100 Detroit, Mich. (March 31, 2025)—Michigan Institute of Urology (MIU), the largest and most well-established urology practice in Southeast Michigan, has been designated as a clinical trial site to assess [...]
Dr. Jason Hafron discusses developments in research for non-muscle-invasive bladder cancer with Targeted Oncology
IN THIS INTERVIEW: Jason M. Hafron, MD, CMO, discusses recent approvals in the non–muscle-invasive bladder cancer space and data from several clinical trials evaluating agents for bladder cancer. Hafron is the chief medical officer and medical director of clinical research [...]
This Sweetest Day, men could snip some flowers or…snip something else!
TROY, MICH. October 1, 2024—Sweetest Day is October 19, which means men may be struggling to find an appropriate gift. The physicians at Michigan Institute of Urology have an idea: Instead of flowers, how about a vasectomy? If men are [...]
This Prostate Cancer Awareness Month, Remember This Important “Point”
New Public Awareness Effort from Michigan Institute of Urology Troy, Mich. (September 3, 2024) - During September’s Prostate Cancer Awareness Month, the Michigan Institute of Urology wants to stress an important point—0.75. If your prostate-specific antigen (PSA) level increases by [...]
REDEEM Nurses appear on AgeWise Health
Meet the nurses at REDEEM Sexual Health and Wellness Center: Courtney Cook, MSN, Madison Wagberg, RN, and Melia Kramer, MSN. They are dedicated to initiating conversations about sexual health for both men and women. Gain insight into their expertise in [...]
Radiology Business talks to CEO Mitchell Hollander, M.D., about integrating interventional radiology procedures at MIU
Interventional radiology’s integration with independent urology practices is a growing trend, according to those involved with one such partnership. The latest example is the Michigan Institute of Urology, which is teaming with Prostate Centers USA to open IR Centers at [...]
Michigan Institute of Urology Opens Dedicated Outpatient Medical Center for Minimally Invasive Health Care
The Michigan Institute of Urology is partnering with Prostate Centers USA and opening IR Centers at MIU, a dedicated outpatient medical center for interventional radiology procedures in Troy. The new center, opening Dec. 27, will provide patients with the option [...]
CBS Detroit talks with Dr. Jason Hafron about prostate cancer rates and the importance of getting tested
Dr. Jason Hafron describes the Movember Men’s Health Initiative which raises awareness and funding for prostate and testicular cancer. He explains the importance of prostate cancer screening and the risk factors that increase the chances of developing prostate cancer. He [...]
Michigan Institute of Urology Opens New Sexual Wellness and Aesthetics Center for Men and Women called REDEEM
Michigan Institute of Urology (MIU), one of the largest independent urology practices with 17 offices across the Detroit metropolitan area, opened a new sexual wellness and aesthetics center for men and women this week. The center, called REDEEM, is in [...]
PSMA update, access appear high for US-based urologists; Dr. Jason Hafron explains what this means for patients
Urologist access to prostate-specific membrane antigen (PSMA)-targeting agents is high among US practitioners, results of an exclusive Urology Times survey indicate. In total, 88% of respondents said they can order PSMA scans locally, with 9% saying they could not, and [...]
Dr. Jason Hafron discusses the ECLIPSE trial evaluating for metastatic castration-resistant prostate cancer
In this interview, Jason M. Hafron, MD, discusses the ECLIPSE trial evaluating 177Lu-PSMA-I&T for metastatic castration-resistant prostate cancer. Hafron is the chief medical officer and medical director of clinical research at the Michigan Institute of Urology, PC, and a professor of [...]